India AI in Healthcare Market Outlook to 2030
By Clinical Domain, By Deployment Model, By Function, By End User, and By Region
Report Overview
Report Code
TDR0375
Coverage
Asia
Published
November 2025
Pages
80
Flexible Purchase Options
Select and purchase only the chapters you need for your strategic decisions
On This Page
Report Overview
Executive summary will be available soon.
Report Coverage
Verified Market Sizing
Multi-layer forecasting with historical data and 5–10 year outlook
Deep-Dive Segmentation
Cross-sectional analysis by product type, end user, application and region
Competitive Benchmarking & Positioning
Market share, operating model, pricing and competition matrices
Actionable Insights & Risk Assessment
High-growth white spaces, underserved segments, technology disruptions and demand inflection points
Review Methodology & Data Structure
Preview report structure, data sources and research framework
Executive Summary
Explore Flexible Purchase Options or Have Limited Budget?
Pay only for relevant chapters • Customizable report sections
Table of Contents
Choose individual sections to purchase. Mix and match as you like.
4.1 Delivery Model Analysis for AI in Healthcare (Cloud SaaS, On-Premises, Edge / Hybrid)
4.2 Revenue Streams in India AI in Healthcare
4.3 Business Model Canvas for India AI in Healthcare
5.1 Freelance / Specialist AI Vendors vs Full-Suite AI Platform Providers
5.2 Investment Models in India AI in Healthcare (bootstrapped vs VC growth vs OEM JV vs public-private partnership)
5.3 Comparative Analysis of the Funneling / Procurement Process in Private vs Government / Public Health Organizations (RFP cycles, pilot-> scale, clinical validation gatekeeping)
5.4 AI / Digital Health Budget Allocation by Hospital / Chain Size, Latest Year
8.1 Revenues, Historical Period (2019-latest)
9.1 By Deployment Model (Cloud, On-Premises, Edge/Hybrid)
9.2 By Clinical Domain (Radiology, Pathology, Cardiology, Ophthalmology, Critical Care, Oncology, etc.)
9.3 By Function (Screening/Triage, Diagnostic Support, Prognostic Prediction, Operational AI, Documentation / Coding)
9.4 By End User / Buyer Type (Tertiary Hospitals, Diagnostic Chains, PHCs / HWCs, Payors / TPAs, Research / Pharma)
9.5 By Company Size / Buyer Scale (Large chains, mid-tier hospitals, single hospitals)
9.6 By Mode of Integration / AI Model Type (plug-in modules, API, embedded in OEM device, full platform)
9.7 By Open vs Customized Solutions
9.8 By Region / State (North, South, East, West, Central)
10.1 Healthcare Client Landscape & Cohort Segmentation
10.2 Decision-Making Process & Buyer Criteria for AI Solutions
10.3 Program Effectiveness, ROI Metrics & Post-Deployment Impact
10.4 Gap Analysis Framework (expectations vs delivered performance)
11.1 Trends & Developments in India AI Healthcare
11.2 Growth Drivers
11.3 SWOT Analysis for India AI in Healthcare
11.4 Issues & Challenges (regulatory uncertainty, data quality, clinician acceptance, liability risk)
11.5 Government Policies & Regulations (ABDM, DPDP, CDSCO SaMD, ethics guidelines, public health AI mandates)
12.1 Market Size & Future Potential of AI-First / Cloud-Native Healthcare Models
12.2 Business Models & Revenue Streams in AI Platforms
12.3 Delivery Models, Solution Types & Use-Cases
15.1 Market Share of Key Players (by revenue, domain coverage, deployment)
15.2 Benchmarking Key Competitors (company overview, USPs, strategy, tech stack, client base, pricing, deployments, funding)
15.3 Operating Model Analysis (centralized AI lab, federated, hybrid, managed services)
15.4 Gartner / Thought Leadership Quadrant for AI in Healthcare
15.5 Strategic Positioning Framework (e.g. Bowman's Clock or similar)
16.1 Projected Revenues over Forecast Period
17.1 By Deployment Model
17.2 By Clinical Domain
17.3 By Function
17.4 By Buyer Type
17.5 By Company / Buyer Scale
17.6 By Mode of Integration / Solution Type
17.7 By Open vs Customized
17.8 By Region
Discuss a Customized Research Scope
Custom research scope • Tailored insights • Industry expertise
Research Methodology
Step 1: Ecosystem Creation
Map the ecosystem and identify all the demand-side and supply-side entities for the India AI in Healthcare Market. Based on this ecosystem, we will shortlist leading 5–6 AI healthcare solution providers in the country based on their product portfolio, deployment maturity, regulatory readiness, and hospital network penetration. Sourcing is conducted through government portals (MoHFW, NHA, MeitY, CDSCO), industry reports, company filings, press releases, and multiple proprietary and secondary databases to perform desk research and collate comprehensive industry-level information.
Step 2: Desk Research
Subsequently, we engage in an exhaustive desk research process by referencing diverse secondary and proprietary databases. This approach enables a deep analysis of the AI healthcare market, aggregating insights on adoption levels, number of AI-deployed hospitals, digital infrastructure readiness, regulatory approvals (SaMD), and interoperability maturity. We assess both macro and micro factors—such as hospital density (714 district hospitals, 31,882 PHCs, 6,359 CHCs) and the extent of ABDM enrollment (6.7 billion ABHA IDs)—to determine AI readiness. Further, company-level data is analyzed using verified filings and public disclosures, covering revenues, funding rounds, number of deployments, strategic collaborations, and compliance certifications (ISO 13485, HIPAA, DPDP). The goal is to construct a foundational understanding of the ecosystem and the entities operating within it.
Step 3: Primary Research
We initiate a series of in-depth interviews with CXOs, clinical directors, CIOs, AI engineers, and regulatory experts representing hospitals, AI startups, payors, and device OEMs. This process serves multiple objectives—validating market hypotheses, authenticating hospital adoption metrics, and extracting operational and financial insights from industry leaders. A bottom-to-top approach is followed to evaluate revenue and deployment contributions for each player, aggregated to form the overall market structure. As part of the validation strategy, our team executes disguised interviews with select hospitals and health-tech integrators posing as enterprise clients. This approach helps validate claims on AI integration, model accuracy, compliance readiness, and pricing models (per-study, per-bed, or subscription). These insights are then corroborated with secondary sources such as CDSCO registration data, ABDM model-facility listings, and government partnership announcements to ensure precision and reliability.
Step 4: Sanity Check
A comprehensive bottom-to-top and top-to-bottom analysis is performed to test the consistency of findings and market size modeling exercises. In the bottom-up approach, we aggregate validated data from AI solution providers and hospitals, including active deployments, contract values, and clinical domains. The top-down approach aligns this with macro indicators such as the total hospital count, diagnostic volumes (2.6 million TB notifications), and digitized OPD registrations (40 million via ABHA Scan & Share). Cross-verification ensures the resulting market structure reflects real-world adoption potential and operational capacity. The sanity process also assesses supply–demand alignment, ensuring interoperability maturity, cybersecurity obligations, and compliance timelines under ABDM and DPDP Act (2023) are consistent with ground-level realities.
See What's Inside the Report
Get a preview of key findings, methodology and report coverage
Frequently Asked Questions
01 What is the potential for the India AI in Healthcare Market?
The India AI in Healthcare Market has immense growth potential, driven by a rapidly digitizing healthcare ecosystem and rising demand for automation across clinical and administrative workflows. The market is valued at USD 758.8 million, supported by initiatives such as the Ayushman Bharat Digital Mission (ABDM), which has generated over 6.7 billion ABHA IDs and connected 131 model facilities nationwide. The integration of AI into diagnostics, claims processing, and hospital operations demonstrates the sector’s strategic importance in improving healthcare delivery and efficiency across India.
02 Who are the Key Players in the India AI in Healthcare Market?
The India AI in Healthcare Market features several prominent players, including Qure.ai, DeepTek, Niramai, Tricog, and SigTuple. These companies dominate through clinically validated AI solutions across radiology, cardiology, and pathology. Other significant contributors include Synapsica, 5C Network, Innovaccer, HealthPlix, and Dozee, known for data-driven EMRs, AI-enabled diagnostics, and real-time patient monitoring. Multinational participants such as GE HealthCare, Philips, and Siemens Healthineers further enhance India’s ecosystem with hardware-integrated AI and large-scale hospital collaborations.
03 What are the Growth Drivers for the India AI in Healthcare Market?
Key growth drivers include strong macroeconomic and healthcare infrastructure indicators. India’s GDP stood at USD 4.19 trillion (IMF, 2024), supporting large-scale healthcare digitization. The government’s ABDM initiative has created over 6.7 billion digital health IDs and enabled 40 million OPD registrations via ABHA, facilitating AI adoption in data-driven diagnostics. Moreover, the Ministry of Health and Family Welfare (MoHFW) reported 360 million eSanjeevani teleconsultations, indicating expanding digital interaction layers for machine learning applications. These macro and digital foundations collectively drive scalable AI integration across healthcare functions.
04 What are the Challenges in the India AI in Healthcare Market?
Despite rapid advancement, the market faces critical challenges in data standardization, infrastructure readiness, and compliance. India’s public healthcare network operates across 169,615 Sub-Centres, 31,882 PHCs, and 6,359 CHCs, reflecting deep structural diversity that complicates uniform AI deployment (MoHFW). Cybersecurity is a major barrier—CERT-In reported 2,041,360 cybersecurity incidents in 2024, necessitating robust data protection protocols under the Digital Personal Data Protection Act, 2023. Additionally, gaps in clinical validation and lack of qualified AI-health specialists continue to slow enterprise-wide adoption.
License Options
PDF + Excel
Complete report package
$4,000
Excel Only
Data and analytics
$2,500
Custom Sections
Starts from $100
$0